An Observational Study to Assess Ubrogepant Tablets and Atogepant Tablets to Treat Migraine in Adult Participants
Clinical trial NCT05827887 · COMPLETED
Trial details
- NCT number
- NCT05827887
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-06-25
- Primary completion
- 2026-01-28
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.